Personalized blood thinner dosing may reduce bleeding risk in heart patients awaiting surgery

NCT ID NCT07225842

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adjusting the dose of the blood thinner cangrelor based on individual test results can better control clotting in people with coronary artery disease who are waiting for surgery. About 50 adults will receive either a standard or tailored dose to find the safest and most effective approach. The goal is to reduce the risk of both blood clots and bleeding during the bridging period before surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Florida Jacksonville

    RECRUITING

    Jacksonville, Florida, 32209, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact